Artificial Intelligence

Doğuş Technology and Doğuş Construction Participate in ConteQ Expo 2024 with Innovative Projects

Retrieved on: 
Sunday, September 15, 2024
Software, Data Management, Sustainability, Technology, Residential Building & Real Estate, Commercial Building & Real Estate, Artificial Intelligence, Environment, Construction & Property, Engineering, Building Systems, Manufacturing, Internet of things, Safety, AI, Occupational safety and health, Strategic planning, Construction, Human, Renewable energy

Doğuş Technology, one of Turkey's leading tech companies, will showcase its innovative, technology-driven solutions for the construction industry at ConteQ Expo 2024, alongside Doğuş Construction, at the Qatar National Convention Center from September 16-18.

Key Points: 
  • Doğuş Technology, one of Turkey's leading tech companies, will showcase its innovative, technology-driven solutions for the construction industry at ConteQ Expo 2024, alongside Doğuş Construction, at the Qatar National Convention Center from September 16-18.
  • Both companies will present their projects that drive sector transformation by enhancing efficiency and sustainability in construction by integrating engineering and technology.
  • Doğuş Technology and Doğuş Construction will share their significant projects and sustainable solutions, developed with a focus on industry experience, with participants.
  • The main solutions to be exhibited at ConteQ Expo 2024 include:
    Advanced Construction Technologies: Innovative construction technologies that provide high efficiency and cost-effectiveness by optimizing project processes.

Pega Announces Quarterly Cash Dividend for Fourth Quarter of 2024

Retrieved on: 
Friday, September 13, 2024
Software, Technology, Artificial Intelligence, Inc.

Pegasystems Inc. (NASDAQ: PEGA), the leading enterprise AI decisioning and workflow automation platform provider, today announced a quarterly cash dividend of $0.03 per share, maintaining the company’s current dividend program.

Key Points: 
  • Pegasystems Inc. (NASDAQ: PEGA), the leading enterprise AI decisioning and workflow automation platform provider, today announced a quarterly cash dividend of $0.03 per share, maintaining the company’s current dividend program.
  • The Q4 2024 dividend will be paid on October 15, 2024, to shareholders of record as of October 1, 2024.

Colibri Real Estate Celebrates National Online Learning Day

Retrieved on: 
Friday, September 13, 2024
Commercial Building & Real Estate, Technology, Construction & Property, Internet, Other Education, Continuing, Training, Education, Artificial Intelligence, Residential Building & Real Estate, Online, Innovation, AI, Real estate, Research, Student, Social media, Content, Customer experience, Learning, Colibri, Tutoring

Colibri Real Estate , the leading provider of real estate education nationwide, today announced its recognition and celebration of National Online Learning Day on September 15th.

Key Points: 
  • Colibri Real Estate , the leading provider of real estate education nationwide, today announced its recognition and celebration of National Online Learning Day on September 15th.
  • Colibri Real Estate offers online learning for every career stage, from getting started to maintaining a license and developing skills for career success.
  • “Every day is a celebration of online learning at our company, and we are excited to have a special day like today to recognize all the people who learn online and enable others to learn online,” said Tina Lapp, Head of Customer Experience and Instruction for Colibri Real Estate.
  • “Colibri Real Estate has transformed our learning experience based on student feedback to make it easier for students to learn, stay engaged in the process and complete their coursework,” said Andrew Robinson, Head of Product, Content, and Innovation, Colibri Real Estate.

Red Hat Recognized as a Leader and Furthest in Vision in 2024 Gartner® Magic Quadrant™ for Container Management

Retrieved on: 
Friday, September 13, 2024
Data Management, Apps, Applications, Technology, Mobile, Wireless, Software, Artificial Intelligence, Internet, Cloud, Red, Completeness, OpenShift, Organization, Challenger, Red Hat, Use case, Gartner, Magic Quadrant, Video game

This report follows the Gartner recognition of Red Hat as a Challenger in the most recent 2024 Gartner Magic Quadrant for DevOps Platforms. As one of the only three vendors named in both Magic Quadrant reports, we believe this showcases Red Hat OpenShift’s capabilities as a fully integrated application development platform -- enabling a standardized developer experience across the hybrid cloud and supporting diverse workloads from AI-enabled to applications at the edge.

Key Points: 
  • Red Hat, Inc., the world's leading provider of open source solutions, today announced that Red Hat has been positioned by Gartner as a Leader and furthest on the Completeness of Vision axis in the Magic Quadrant for Container Management for its Red Hat OpenShift offering.1 Additionally, Red Hat ranked first in three of six Use Cases in the 2024 Gartner Critical Capabilities for Container Management, including Hybrid Container Development, Container Management Tooling and Edge Container Deployment.
  • Red Hat OpenShift is a comprehensive platform for developing, modernizing and deploying applications at scale, including AI-enabled apps.
  • This report follows the Gartner recognition of Red Hat as a Challenger in the most recent 2024 Gartner Magic Quadrant for DevOps Platforms .
  • Mike Barrett, vice president and general manager, Hybrid Cloud Platforms, Red Hat
    “We are proud to be recognized as a Leader and Furthest in Completeness of Vision in the Gartner Magic Quadrant for Container Management.

Best Generative AI Courses (2024): Udacity Gen AI Courses Reviewed by Compare Before Buying

Retrieved on: 
Friday, September 13, 2024
Other Education, Technology, Artificial Intelligence, Software, Education, PyTorch, Custom, Deep learning, AWS, Curriculum, Amazon Web Services, AI, Knowledge, Q&A, Engineering, OpenAI, Generative, API, Synthetic media, Data, ChatGPT, Student

This course offers a comprehensive introduction to generative AI, focusing on LLMs and text generation, as well as AI image generation concepts.

Key Points: 
  • This course offers a comprehensive introduction to generative AI, focusing on LLMs and text generation, as well as AI image generation concepts.
  • These courses from Udacity not only enhance technical skills but also prepare professionals to navigate the complexities of generative AI in their respective fields.
  • Click here and browse the wide selection of the best generative AI courses from Udacity.
  • For a more in-depth review of the Generative AI nanodegree program, Generative AI Fluency, How to Use ChatGPT Fluency, Introducing Generative AI with AWS, and Building a Custom OpenAI Chatbot, please visit the Compare Before Buying website .

Intelecy announces Anna Olsson’s promotion to Chief Operating Officer

Retrieved on: 
Friday, September 13, 2024
Manufacturing, Artificial Intelligence, Software, Technology, Mining, Minerals, Other Energy, Forest Products, Utilities, Oil, Gas, Agriculture, Alternative Energy, Natural Resources, Energy, Other Manufacturing, Steel, Machinery, Engineering, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics, CCO, AI, Growth, Microsoft, Cognite, Medical device

Intelecy, a leading Norwegian industrial AI company, is excited to announce the promotion of Anna Olsson from Chief Commercial Officer (CCO) to Chief Operating Officer (COO).

Key Points: 
  • Intelecy, a leading Norwegian industrial AI company, is excited to announce the promotion of Anna Olsson from Chief Commercial Officer (CCO) to Chief Operating Officer (COO).
  • Anna Olsson, who joined Intelecy with over 20 years of experience in the software industry, has been instrumental in driving the company’s commercial strategy and internationalization.
  • With Anna leading our operations, we are confident in scaling our impact and expanding Intelecy’s global footprint," says Camilla Gjetvik, CEO of Intelecy.
  • This new chapter for Intelecy, under the operational leadership of Anna Olsson, marks an important step towards expanding industrial AI solutions on the global stage.

LifestyledAI, Dongguk University Startup Technology Institute, and UMUST R&D Partner to Advance Global AI Deep Tech and Healthcare Businesses

Retrieved on: 
Friday, September 13, 2024
Software, Professional Services, Start-Up, Apps, Applications, Technology, Medical Devices, University, Artificial Intelligence, Fashion, Health Technology, Education, Retail, Health, Dongguk University, AI, MOU, Beauty, Technology transfer, Partnership, Multimedia, Medical device

On August 28, 2024, Dongguk University Startup Technology Institute announced the signing of a joint MOU with LifestyledAI Co., Ltd. and UMUST R&D to advance global deep tech and healthcare initiatives through the application of LifestyledAI's cutting-edge, proprietary AI technologies (patent-pending).

Key Points: 
  • On August 28, 2024, Dongguk University Startup Technology Institute announced the signing of a joint MOU with LifestyledAI Co., Ltd. and UMUST R&D to advance global deep tech and healthcare initiatives through the application of LifestyledAI's cutting-edge, proprietary AI technologies (patent-pending).
  • With a vision to become a global leader in the practical application of AI image technology, LifestyledAI is dedicated to enhancing user convenience in the fashion and beauty e-commerce industries through its innovative AI solutions.
  • UMUST R&D Co., Ltd. is a renowned global healthcare startup focused on the development of global healthcare and AI technologies.
  • Jinwan Kim, CEO of LifestyledAI, stated, "This partnership will allow us to further refine our proprietary AI technologies and accelerate their global commercialization, helping to advance the AI deep-tech and healthcare industries on a global scale."

Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024

Retrieved on: 
Friday, September 13, 2024
Other Health, Research, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Health Technology, Science, Biotechnology, FDA, Other Science, Health, Poster, Circulating tumor DNA, Tempus, Prognosis, DNA, Patient, RAS, BRAF, Clinical trial, Cleveland Clinic, Historic Environment Scotland, ESMO, TKI, SNV, Congress, Abstract, TIME, CRC, Data, Neoplasm, MRS, TF, Survival, MD, MSI, VAF, CGP, NSCLC

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2024, which convenes in Barcelona, Spain, from September 13-17, 2024.

Key Points: 
  • Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2024, which convenes in Barcelona, Spain, from September 13-17, 2024.
  • "ESMO provides a great platform to share our recent research and advancements with the global oncology community, foster further collaboration, and drive forward the mission of improving patient outcomes,” said Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus.
  • Utilizing AI for patient matching and accelerating trial activation is recommended to maximize clinical trial success.
  • Using the Tempus xM ctDNA assay, patients were classified as molecular responders (MRs) or non-responders (nMRs) based on changes in ctDNA tumor fraction (TF).

ENET Unveils Cost-Efficient 100G ZR QSFP28 DCO DWDM Tunable Transceiver for the Optical Edge

Retrieved on: 
Friday, September 13, 2024
Data Management, Consumer Electronics, Technology, Networks, Artificial Intelligence, Hardware, Research, DCO, ENET, Growth, AI, AOC, Stock, NSI, OEM, QSFP28, Wavelength-division multiplexing, DAC, DWDM, Travel, Multimedia, HVAC

ENET, an NSI Industries brand, a leader in compatible optical networking solutions, is proud to announce the release of its 100G ZR QSFP28 DCO DWDM Tunable Transceiver.

Key Points: 
  • ENET, an NSI Industries brand, a leader in compatible optical networking solutions, is proud to announce the release of its 100G ZR QSFP28 DCO DWDM Tunable Transceiver.
  • This cost-efficient, low-power 100G QSFP28 transceiver is specifically designed for the optical edge, addressing the growing need for upgrading edge aggregation infrastructure to 100Gbit/s rates as data traffic continues to surge.
  • This innovative solution significantly increases network capacity by incorporating Dense Wavelength Division Multiplexing (DWDM) technology, allowing multiple signals to travel over the same fiber.
  • View the full release here: https://www.businesswire.com/news/home/20240913970406/en/
    The 100G QSFP28 DCO DWDM Transceiver from ENET designed for the optical edge.

Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care

Retrieved on: 
Friday, September 13, 2024
Technology, Clinical Trials, Health Technology, Software, Biotechnology, Pharmaceutical, Health, Data Management, Oncology, Artificial Intelligence, Foundation Medicine, Patient, Roger Hawkins (drummer), Physician, Clinical trial, AI, NGS, Senior, Partnership, Cancer, MD, Multimedia, Medical imaging

Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient access to cutting edge clinical trials.

Key Points: 
  • Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient access to cutting edge clinical trials.
  • View the full release here: https://www.businesswire.com/news/home/20240913830674/en/
    Massive Bio partners with Foundation Medicine to enhance clinical trial recruitment and expand access to precision cancer care.
  • Joining forces with Foundation Medicine is pivotal as it will allow us to develop solutions to the cancer clinical trial enrollment paradox."
  • “Through this partnership with Massive Bio, we have the patient at the forefront, leveraging our combined assets and expertise to improve access to clinical trials for patients.”